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Table 2
Parameter Group 1 (n = 110) Group 2 (n = 110) p
24-hour SBP (mmHg) 120.1  9.1 117.8  6.0 0.02
24-hour DBP (mmHg) 76.0  7.2 74.0  6.5 0.03
24-hour MABP (mmHg) 90.7  7.8 87.9  5.9 <0.01
24-hour HR (bpm) 75.8  8.1 76.2  6.3 0.72
Daytime SBP (mmHg) 124.3  9.3 121.9  6.7 0.03
Daytime DBP (mmHg) 79.3  7.5 78.1  7.5 0.24
Night-time SBP (mmHg) 113.7  9.1 109.4  6.0 <0.01
Night-time DBP (mmHg) 69.8  7.5 66.5  5.2 <0.01
D Day-Night SBP (mmHg) 9.0  4.4 10.5  4.2 0.01
D Day-Night DBP (mmHg) 11.1  5.9 14.0  6.4 <0.01
Early Morning
Average SBP (mmHg)
111.7  11.0 109.8  12.8 0.31
Early Morning
Average DBP (mmHg)
68.7  9.4 66.2  12.8 0.17
Ambulatory blood pressure monitoring results of the patients (group 1) and control subjects
(group 2).
P
O
S
T
E
R
SPP-031
Post Marketing Surveilance Studies of Antihypertensive Drugs in Syria
Walid Bsata
Alepoo University Heart Hospital, Syria
Hypertension accounts for number of morbidities and mortalities in Syria. We know
that each speciﬁc population has its own particulars and might have different
responses to drugs due to pharmacokinetics and pharmacodynamics. In Syria, there
are many national pharmaceutical companies which produce multiple antihypertensive
drugs.
In order to comply with Evidence Based Medicine, we studied two antihypertensive
drugs produced by these companies. Two large Post Marketing Surveillance studies
were carried out and they were the pioneer efforts in Syria. They looked at efﬁcacy,
safety and tolerability of Rennin Angiotensin Aldosterone System suppressing drugs.
The ﬁrst study VHEST (Valsartan in Hypertension, Efﬁcacy, Safety and Toler-
ability) and the second study REST (Revosyl Efﬁcacy, Safety and Tolerability)
while Revosyl is the market name for Perindopril.
These studies were done by a protocol put by an experienced hypertensive specialist
and carried out by number of physicians in different geographic locations in Syria.
These studies were open label, controlled, observational, prospective, post marketing,
non interventional clinical studies.
VHEST included 1500 essential hypertension patients (grade I, II and Isolated
systolic hypertension) with a follow up of 12 weeks. Investigators were 100 physi-
cians (Cardiologists, Endocrinologists, Neurologists, Internists and Nephrologists).
Conclusion was that Valsartan  HCTZ is efﬁcacious, well tolerated and safe. The
most reported side effects were headache& dizziness.
REST included 2250 patients with Essential Hypertension (Grade I, II& Isolated
Systolic Hypertension). Follow up was 12 weeks and 141 physicians participated. It
showed that Perindopril is efﬁcacious with an acceptable level of systolic and diastolic
blood pressure reduction and a good control and response rates. The concomitant
presences of CHF or renal disease were associated with intense reduction of DBP
while patients with concomitant cerebrovascular accidents or left ventricular hyper-
trophy showed a tendency to reduce SBP easier. The most frequently reported side
effects were cough& headache.
In conclusion, antihypertensive drugs produced by national pharmaceutical
companies are reasonable choice for treating patients with hypertension.
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Inﬂuence of Some Antidepressants from Group of the Selective Inhibitors of
Recapture of the Serotonin and the Extract of Common St. John’s Wort
(Hypericum Perforatum) on the Psychologıcal Status of the Patients with Arterial
Hypertension
Orazberdiyev Yazmuhammet Basimovich1
1Hospital With the Science-Clinical Centre of Cardiology, Turkmenistan, 2Turkmen
State Medical University, Turkmenistan
Depressive disorders of an mild and medium degree of severity at cardiological
patients at present are one of actual problems of modern medicine. It became possible
in spite of the fact that last years there was a lot of the new highly effective antide-
pressants which are not possessing unlike to classical tricyclic antidepressant, the
expressed behavioural toxicity and negative inﬂuence on activity of cardiovascular
system. Besides medicamentous therapy in the literature there are reports on efﬁciency
of herbal therapy as antidepressants (Wonnemann M. And co-authors., 2000). One of
the most effective in a therapeutic practice of plants is common St. John’s wort,
(Hypericum perforatum).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTThe purpose of research. To study comparative efﬁciency of some antidepressants
from group of selective inhibitors of recapture of the serotonin (SIRS) and an extract of
St. John’s wort, (Hypericum perforatum) in treatment of depressive disorders at arterial
hypertension (AH) patients with (AH) with the hypertensive encephalopathy (HE).
Results of research. The comparative analysis of results has shown, that in all
groups of treatment by 3 month as a whole at 86,6% of patients are reached special-
purpose values the of AH and stabilization of clinical course of HE (p<0,001), 68,3%
of patients have returned to a former level of psychosocial functioning (p<0,001).
Improvement of a psychological condition was shown in reduction of emotional
lability, anxiety, phobia, depression, sleep disturbance, improvement of mood and
efﬁciency. The retrospective analysis of results of treatment has shown, that each of
used SIRS had some features of psychotropic action.
At prescription to patients with AH with HE of 15 gr/daily an extract of St. John’s
wort, (Hypericum perforatum) if the initial score with depressive disorders on scale
Beck made 22,61,2 in the subsequent it is statistically certainly (p<0,05) has
decreased up to 13,81,1 points. In 2 months from the beginning of reception of an
extract of St. John’s wort, (Hypericum perforatum) at AH patients with psychological
disorders, decrease of depression was marked on 35% from initial. Efﬁciency of
therapy with an extract of St. John’s wort, (Hypericum perforatum) to the end of third
months of supervision has averaged 55% (p<0,05).
Conclusions: On the basis of the received results it has been proved, that at AH
patients with HE for correction of depressive disorders is necessary the differentiated
setting of antidepressants from group of selective inhibitors of recapture of serotonin.
Application of an extract of St. John’s wort, (Hypericum perforatum) in a dose of 15
gr/daily show the positive antidepressive effect, but this effect on anxiously- phobic
disorders was insufﬁciently.
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Hypertension in Patients with Hypertensive without Clinically Overt
Cardiovascular Disease
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Hüseyin Uyarel2, Nevzat Uslu1
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Surgery Center, Training and Research Hospital, Istanbul, 2Department of
Gastroenterology, Bezmialem Vakıf University, School of Medicine, Istanbul,
3Department of Cardiology, Okmeydanı, Training and Research Hospital, Istanbul
The circulating level of NT-pro BNP serves as a sensitive marker of left ventricular
hypertrophy and volume expansion. it has been demonstrated that hypervolemia, an
increase in sympathetic function may co ntribute to the occurrence of the non-dipping
phenomenon Also both higher NT-pro BNP levels and non-dipper hypertension have
been shown to predict cardiovascular events and mortality in the general pop-
ulation.Thus, the aim of this study is to determine whether an association exists
between NT-BNP and non-dipper hypertension and to evaluate the predictive value of
N-Terminal- pro brain natriuretic peptide (NT-proBNP) in non-dipping pattern in
patients with hypertensive.
Methods: We enrolled 333 consecutive hypertensive patients with no cardiovascular
disease (mean age 49.910.8 years, %50.6 men). Ambulatory blood pressure moni-
toring was performed in all patients and according to the values of ambulatory BP, the
patients were divided into two groups. Non-dipper hypertensive group (n¼177),
dipper hypertensive group (n¼155).
Results: NT-pro BNP was higher in non-dipper hypertensive group than in dipper
hypertensive group (81.5 94 pg/ml, 48.766 pg/ml, p <0.001 respectively). There
was correlation between NT-pro BNP and systolic blood pressure (especially at night),
age (r¼0.233, p<0.001, r¼0.339, p<0.001). NT-pro BNP was no correlation with
diastolic blood pressure. In logistic multivariate analysis; NT-pro BNP value was
found to be a independent predictor of non-diping pattern development (odds ratio:
1.022, 95% conﬁdence interval: 1.007-1.038, p<0.05) and In a receiver operating
characteristic (ROC) curve analysis, a BNP value of 38.5 pg/ml was identiﬁed as an
effective cut-off point for Non-dipper hypertension (area under curve¼0.663, 95%
conﬁdence interval (CI) 0.64 to 0.721, p<0.001). NT-pro BNP of > 38.5 pg/ mL
yielded a sensitivity of 61.6% and a speciﬁcity of 60% for non-dipper hypertension.
Conclusıons: These results suggest that non-dipper pattern could be identiﬁed using
the NT-pro BNP level in patients with hypertensive without clinically overt cardio-
vascular disease and renal failure in clinical practice.ERS C95
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Circadian Blood Pressure (CBP) Alterations and Other Etiological Risk Factors
in Patients with Lacunar Infarction
Ali Kemal Erdemoglu1, Gökhan Keskin2
1Acıbadem Hospitals Group Ankara, Neurology Clinic, Ankara, 2Acıbadem Hospitals
Group Ankara, Cardiology Clinic, Ankara
Background: Although the occurrence of lacunar infarction is closely related to
arterial hypertension. The possible pathogenetic role of circadian blood pressure
changes is controversial. This study was designed to evaluate the relationship between
circadian blood pressure changes and occurrence of lacunar infarct in respect of other
possible risk factors.
Methods and Patients: Patients, older than 50 years old who were admitted to our
clinic were evaluated to detect the circadian blood pressure pattern, occurrence of
lacunar infarct and other risk factors. Twenty-nine patients with lacunar infarct and 29
controls were included into the study consecutively between 2011-2013 years.
Detailed information and neurological examination were done. Ambulatory 24-hour
noninvasive blood pressure measurements, electrocardiography, laboratory examina-
tions (biochemical and hematological parameters) were performed. Carotid and
vertebral system Doppler investigational and magnetic resonance imaging or
computed tomography was done for each patient. Variation in systolic and diastolic
blood pressure was deﬁned as the difference between night and daytime.
Results: Patients with lacunar infarct was signiﬁcantly older and showed more often
a history of arterial hypertension (p:0.02). Daytime and nighttime blood pressure
values were signiﬁcantly greater than controls (p<0.01). A reduced circadian blood
pressure variation due to increased nighttime values was found different from controls.
In the logistic regression analysis, a reduced systolic circadian blood pressure varia-
tion (p<0.01, OR: 15.1 95%CI, 4.2-54.5), age (p:0.03 OR, 1.01; 95% CI, 1.01-1.19),
history of hypertension (p:0.001 OR, 4.84; 95% CI, 1.47-15.97) and nighttime systolic
blood pressure values (p<0.001 OR, 1.11, 95% CI, 1.05-1.17) were found to be
determinants of lacunar infarction.
Conclusıon: Reduced systolic circadian blood pressure variation may be an important
factor for the occurrence of lacunar infarction besides age and history of hypertension.
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Depression and Anxiety are Associated with Abnormal Nocturnal Blood Pressure
Fall in Hypertensive Patients
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1Marmara University Faculty of Medicine, Department of Cardiology, Istanbul,
2Erenkoy Training and Research Hospital for Psychiatric and Neurological
Disorders, Psychiatry Clinic, Istanbul
Background: Previous studies have shown that depression and anxiety were inde-
pendent risk factors for hypertension. Non-Dipper hypertension is associated with
higher cardiovascular mortality. The aim of this study was to evaluate the anxiety and
depression scores in patients with dipper and non-dipper hypertension.
Methods: The study sample consisted of 153 hypertensive patients. All patients
underwent 24-hour blood pressure monitoring. Patients were classiﬁed into two
groups according to their dipper or non-dipper hypertension status. We evaluated
results of the Hospital Anxiety and Depression Scale between groups.
Results: Seventy-eight patients (38 male, mean age:51.612.5 years) had dipper
hypertension while 75 patients (27 male, mean age:55.414.1 years) had non-dipperC96 JACC Vohypertension (p¼0.141, 0.072, respectively). Clinical characteristics were similar for
both groups. Patients with non-dipper hypertension had signiﬁcantly higher depres-
sion and anxiety scores compared to patients with dipper hypertension (Figure1).
Dipper and non-dipper status signiﬁcantly correlated with anxiety (p:0.025, r:0.181)
and depression score (p:0.001, r:0.255). In univariate analysis, smoking, alcohol
usage, presence of diabetes, hyperlipidemia, anxiety score more than 8, and depression
score more than 7 were predictors of dipper versus non-dipper status. In multivariate
logistic regression analyses only depression score more than 7 was independent
predictor of dipper versus non-dipper status (odds ratio:2.74, conﬁdence inter-
vals:1.41-5.37). A depression score of 7 or higher predicted non-dipper status with
a sensitivity of 62.7% and speciﬁcity of 62.8%.
Conclusıon: Non-dipper patients have signiﬁcantly higher anxiety and depression
scores compared to dipper patients. Evaluation of anxiety and depression in patients
with hypertension might help to detect non-dipper group and hence guide for better
management.PP-036
Evaluation of Arterial Stiffness and Hemodynamics by Oscillometric Method in
Patients with Systemic Sclerosis
Murat Sunbul1, Kursat Tigen1, Gulsen Ozen2, Erdal Durmus1, Tarik Kivrak1,
Altug Cincin1, Alper Kepez1, Halil Atas1, Haner Direskeneli2, Yelda Basaran1
1Marmara University Faculty of Medicine, Department of Cardiology, Istanbul,
2Marmara University Faculty of Medicine, Department of Rheumatology, Istanbul
Objectıves: Arterial stiffness and its hemodynamic consequences are associated with
adverse cardiovascular events. Pulse wave velocity and augmentation index are non-
invasive markers of arterial stiffness. Systemic sclerosis (SSc) is a systemic, auto-
immune disease affecting mainly small vessels. The aim of this study was to evaluate
the arterial stiffness parameters and hemodynamics by oscillometric method in
patients with SSc.
Methods: Thirty-ﬁve consecutive patients with diagnosed SSc and 35 age- and sex-
matched healthy controls were included in the study. Measurements of arterial stiff-
ness were carried out by using a Mobil-O-Graph arteriograph system that detected
signals from the brachial artery.
Results: While hemodynamic parameters were not statistically signiﬁcant between
SSc and control groups, heart rate was signiﬁcantly higher in SSc group (8412 beat/
min and 727 beat/min, p¼0.001). SSc patients had signiﬁcantly higher augmentation
index and pulse wave velocity values compared to controls (27.912.4% versus
21.011.4%, p¼0.019 and 6.561.5 m/s versus 5.040.17 m/s, p<0.001, respec-
tively) (Figure 1). PWV was signiﬁcantly associated with SSc when adjusted by heart
rate (p¼0.001, odds ratio: 17.304, 95% conﬁdence interval: 3.225 – 92.832).
Conclusıons: Pulse wave velocity and augmentation index were signiﬁcantly higher
in patients with SSc. Measurement of arterial stiffness parameters using oscillometric
method was reliable, reproducible and, easy in patients with SSc.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
